Bioengineer.org: Biomarker may aid in determining treatment for cancer patients
UC medical student leads research to aid treatment of glioblastoma
Patients with glioblastomas or malignant brain tumors, face a difficult future. The disease is fatal, and only about 5 percent of patients are alive five years after their diagnosis, explains Haidn Foster, a third-year medical student at the UC College of Medicine and first author of a recent study of glioblastoma patients in the scholarly journal Neuro-Oncology Advances.
The findings were reported by Bioengineer.org, a biotechnology news service.
Foster’s study looked at health outcomes of 188 glioblastoma patients and found that individuals who tested positive for an antibody indicating Human cytomegalovirus (HCMV) exposure lived an average of 404 days after their cancer diagnosis compared to an average of 530 days for patients who were never infected by HCMV.
A life expectancy difference of four months is an important consideration for patients and their physicians. “For glioblastoma patients time is precious and treatment that would prolong life by a few weeks or months is considered a victory,” said Foster.
Related Stories
UC summer program gives high school students hands-on research experience
March 18, 2026
The University of Cincinnati College of Medicine is expanding its Medical Sciences Summer Institute (MSSI) this year with a new medical informatics track.
How the University of Cincinnati co-op program is shaping the future of work at SXSW
March 17, 2026
The University of Cincinnati served as a 2026 Workplace Track sponsor at the annual South by Southwest (SXSW) Innovation Conference March 12-18 in Austin, Texas, showcasing how co-op is redesigning the future of work.
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.